Taxol paclitaxel: Phase III; marketed to treat metastatic carcinoma of the ovary, breast cancer after failure of combination chemotherapy for metastatic disease

Data from over 3000 patients showed that the combination of Taxol with standard treatment of doxorubicin plus cyclophosphamide reduced mortality by 26 percent and risk of cancer recurrence by 22 perce...